Please assess the completion status of the following clinical trial:

Trial Title: Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients from 3 months to 10 years of age.~* Patients diagnosed of dermatomycoses produced by yeasts or dermatophytes by KOH technique at the inclusion moment, which has to be confirmed by culture.~* Obtention of the informed consent of the parents or legal representatives of the patients~Exclusion Criteria:~* Previous treatment with oral or topical antifungal drugs.~* Hypersensitivity to ciclopirox olamine or some of the cream excipients.~* Use of topical or oral steroids concomitantly.~* Patients with mycoses on the scalp or nails.

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: 10 Years
- Healthy Volunteers: f

Study Arms:
- ciclopirox (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).